ArticleSignal transduction and targeted therapy2021

FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation.

Ruiqi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.